References (Patients)

  1. Habif TP. Atopic dermatitis. In: Habif TP, ed. Clinical Dermatology. 5th ed. St. Louis, MO: Mosby; 2010:chap 5.
  2. Eichenfield LF, Hanifin JM, Lugar TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003;49:1088-1095.
  3. Larsen FS, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am. 2002;22:1-24.
  4. Eczema. Mayo Clinic website. Available at: http://www.mayoclinic.com/health/eczema/DS00986. Accessed June 7, 2011.
  5. Psoriasis. Mayo Clinic website. Available at: http://www.mayoclinic.com/health/psoriasis/DS00193/. Accessed June 7, 2011.
  6. Del Rosso J, Friedlander SF. Corticosteroids: options in the era of steroid-sparing therapy. J Am Acad Dermatol. 2005;53(1 suppl 1):s50-s58.
  7. National Psoriasis Foundation website. Topical steroid potency chart. Available at: http://www.psoriasis.org/Page.aspx?pid=469. Accessed June 7, 2011.
  8. Royal Society of Chemistry Website. Advanced Chemistry Development, Inc., chemical database. Available at: http://www.chemspider.com/. Accessed June 7, 2011.
  9. Goa KL. Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review. Drugs. 1988;36(Suppl 5):51-61.
  10. Siddiqui O, Roberts MS, Polack AE. Percutaneous absorption of steroids: relative contributions of epidermal penetration and dermal clearance. J Pharmacokinet Biopharm. 1989;17(4):405-424.
  11. Cloderm® Cream [package insert]. Promius Pharma, LLC: Bridgewater, NJ; 2008.
  12. Menter A, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60(4):643-659.
  13. Rosenthal AL. Clocortolone pivalate: a paired comparison clinical trial of a new topical steroid in eczema/atopic dermatitis. Cutis. 1980;25(1):96-98.
  14. Data on file. Promius Pharma,LLC: Bridgewater, NJ. 2011.
  15. Long CC, Mills CM, Finlay AY. A practical guide to topical therapy in children. Br J Dermatol. 1998;138(2):293-296.
  16. Bikowski J, Pillai R, Shroot B. The position not the presence of the halogen in corticosteroids influences potency and side effects. J Drugs Dermatol. 2006;5(2):125-130.
  17. Baeck M, Chemelle JA, Rasse C, Terreux R, Goosseens A. C(16)-methyl corticosteroids are far less allergenic than the non-methylated molecules. Contact Dermatitis. 2011;64(6):305-12.
  18. Data on file. Promius Pharma,LLC: Bridgewater, NJ. 2011.
  19. Maibach HI. Adrenal suppression study on Cloderm. Data on File. Promius Pharma, LLC: Bridgewater, NJ.
  20. Jacob SE, et al. J Am Acad Dermatol. 2006;54(4):723-727.